Serevent® Diskus®

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyPulmonary Disease, Chronic Obstructive

Phase 1

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

CompletedNCT02254174

Boehringer IngelheimHealthy

Start: 2006-03-31Updated: 2014-10-01

Phase 2

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02238106

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-09-30Updated: 2014-09-12

Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02242227

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-09-30Updated: 2014-09-17